Incidence rates increased by 3% annually among adults aged 20 to 49 years and by 0.4% annually for those aged 50 to 64 years.

HealthDay News — The prevalence of obesity and severe obesity markedly increased among adults and children in the US from the 1970s and 1980s until now, according to two reports published in the ...

Review reveals refusal tied to significantly higher risk for life-threatening brain bleeds and long-term neurological disability.

Prevalence of hypertension, diabetes, and obesity estimated to increase, while hypercholesterolemia set to decline ...

Since the 1990s, the FDA has collected fees from drug companies to help pay for stepped-up staffing enable faster reviews of new prescription drugs and vaccines. In turn, the agency must meet certain ...

While GLP-1 receptor agonists were initiated for other health reasons, they were tied to less need for migraine prevention medications.

Long-term morbidity varies by chemotherapy regimen, with higher odds of worse renal impairment seen with EPx4 vs BEPx3.

HealthDay News — Measles cases are climbing rapidly across the US, with more than 1100 infections reported in the first 2 months of this year, data shows. As of February 26, 1136 cases had been ...

Somapacitan, a long-acting human growth hormone analog, was evaluated in growth hormone treatment-naïve, pre-pubertal pediatric patients.

Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.

New study results presented at AAAAI 2026 show significant steroid burden in pediatric asthma patients before the initiation of biologic therapy.

The Food and Drug Administration (FDA) has expanded the approval of Palynziq ® (pegvaliase-pqpz), a phenylalanine (Phe)-metabolizing enzyme, to include treatment of adolescent patients 12 years of age ...